GDF15 and Barth syndrome: The precise molecular mediators linking mitochondrial dysfunction to these systemic responses remain unclear but may include upregulation of glucose transporters in target tissues, an increased insulin-to-glucagon ratio and other circulating factors such as GDF-15, which has also been shown to be elevated in individuals with BTHS [44].